Wilson M. Compton, M.D., M.P.E. is Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health, where he has worked since 2002. NIDA supports most of the world’s research on health aspects of drug abuse, related to preventing drug abuse, treating addiction and addressing serious health consequences of drug abuse. Dr. Compton received his undergraduate education at Amherst College and medical education, including psychiatry training, at Washington University in St. Louis. Over his career, Dr. Compton has achieved multiple scientific accomplishments. He has authored over 200 publications and often speaks at high-impact venues. He was a member of DSM-5’s Revision Task Force and has led, for NIDA, development of the Population Assessment of Tobacco and Health Study, a longitudinal population study, jointly sponsored by NIDA and the U.S. Food and Drug Administration (FDA), with 45,971 baseline participants. Dr. Compton has received multiple awards, including the American Psychiatric Association’s 2008 Senior Scholar Health Services Research Award, the American Psychopathological Association’s 2010 Paul Hoch Award, FDA awards for collaboration in 2012, 2013 and 2017, and the Health and Human Services Secretary’s Awards for Meritorious Service in 2013 and Distinguished Service in 2015, 2018 and 2019.